Effects of High Cut-off (HCO) Hemodialysis on Central Memory CD4+ T and Treg Cells in Patients With End-stage Kidney Disease

Clinical trial NCT01103076 · UNKNOWN

Trial details

NCT number: NCT01103076
Sponsor: Centre Hospitalier du Centre du Valais
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

End-stage Kidney Disease CD4 T Cells Central Memory T Cells Regulatory T Cells Uremic Toxins

Start date: 2011-04-01
Primary completion: 2011-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.